Mother shares journey of daughter’s battle with extreme atopic eczema in Levanger, Norway
At just 1.5 years old, Elena Vist, now 6, began showing classic signs of atopic eczema, experiencing dry skin, rashes, and patchy flare-ups aggravated by cold weather. Initially, her mother, Monica, thought it was standard eczema. However, the condition escalated over the next four years, causing severe discomfort.
Elena endured oozing rashes on her face, hardened sores, and bacterial infections. Her diet had to be carefully managed, and dental issues led to the extraction of four teeth. Each winter brought worsening symptoms, typically starting with a small red spot on her nose that would spread.
Monica recalls the challenges of caring for a child in constant pain. They consulted numerous doctors and dermatologists, received varying treatments, and attempted many creams and ointments without success. The breakthrough came when they finally visited a new general practitioner who recognized the severity of Elena’s condition after observing her deteriorating skin.
Admitted to Levanger Hospital, they encountered astonishment from medical staff over the prolonged suffering within the family. Elena, diagnosed with extreme atopic eczema, was placed on a new treatment regimen, involving a biological medication approved in 2023.
While the majority of atopic eczema cases begin in early childhood, the treatment offers long-term symptom control and can significantly improve quality of life. Experts stress the importance of timely referrals to specialists for severe cases, as delayed treatment can impact families significantly.
Now, Elena enjoys everyday activities like eating strawberries and playing outdoors without restrictions, and Monica is relieved that her daughter can participate fully in life without the stigma of visible eczema.